Structural and functional insights into Erwinia carotovora L-asparaginase

FEBS Journal

Volumn 275, Issue 17, 2008, Pages 4306-4316

  Papageorgiou, Anastassios C ^a   Posypanova, Galina A ^b   Andersson, Charlotta S ^a   Sokolov, Nikolay N ^c   Krasotkina, Julya ^c  

^a UNIVERSITY OF TURKU   (Finland)

^b INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^c INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

Author keywords

Asparaginase; Crystal structure; Enzyme therapy; Erwinia; Leukemia treatment

Indexed keywords

ANTILEUKEMIC AGENT; ASPARAGINASE; BACTERIAL ENZYME; GLUTAMINASE; UREA;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CRYSTAL STRUCTURE; CRYSTALLOGRAPHY; CYTOTOXICITY; DENATURATION; DYNAMICS; ENZYME ACTIVITY; ENZYME STRUCTURE; ESCHERICHIA COLI; EXPERIMENT; HUMAN; HUMAN CELL; INTROSPECTION; LEUKEMIA CELL LINE; NONHUMAN; PECTOBACTERIUM CAROTOVORUM; PRIORITY JOURNAL; STEREOCHEMISTRY; THERMOSTABILITY;

AMINO ACID SEQUENCE; ASPARAGINASE; BASE SEQUENCE; BINDING SITES; CELL LINE, TUMOR; DNA PRIMERS; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PECTOBACTERIUM CAROTOVORUM; PROTEIN CONFORMATION; SEQUENCE HOMOLOGY, AMINO ACID;

BACTERIA (MICROORGANISMS); ERWINIA; ESCHERICHIA COLI; PECTOBACTERIUM CAROTOVORUM;

EID: 49349096755     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2008.06574.x     Document Type: Article

References (46)

1. Campbell HA, Mashburn LT, Boyse EA Old LJ (1967) Two L-asparaginases from Escherichia coli B. Their separation, purification, and antitumor activity. Biochemistry 6, 721 730.
2. Duval M, Suciu S, Ferster A, Rialland X, Nelken B, Lutz P, Benoit Y, Robert A, Manel AM, Vilmer E et al. (2002) Comparison of Escherichia coli-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer - Children's Leukemia Group phase 3 trial. Blood 99, 2734 2739.
3. Gökbuget N Hoelzer D (2006) Treatment of adult acute lymphoblastic leukemia. Hematol Am Soc Hematol Educ Program 1, 133 141.
4. Verma N, Kumar K, Kaur G Anand S (2007) L-asparaginase: a promising chemotherapeutic agent. Crit Rev Biotechnol 27, 45 62.
5. Holcenberg J (2005) New insights on asparaginase. J Pediatr Hematol Oncol 27, 246 247.
6. Ollenschlager G, Roth E, Linkesch W, Jansen S, Simmel A Modder B (1988) Asparaginase-induced derangements of glutamine metabolism: the pathogenetic basis for some drug-related side-effects. Eur J Clin Invest 18, 512 516.
7. Swain AL, Jaskólski M, Housset D, Rao JK Wlodawer A (1993) Crystal structure of Escherichia coli L-asparaginase, an enzyme used in cancer therapy. Proc Natl Acad Sci USA 90, 1474 1478.
8. Aghaiypour K, Wlodawer A Lubkowski J (2001) Structural basis for the activity and substrate specificity of Erwinia chrysanthemi L-asparaginase. Biochemistry 40, 5655 5664.
9. Lubkowski J, Palm GJ, Gilliland GL, Derst C, Röhm KH Wlodawer A (1996) Crystal structure and amino acid sequence of Wolinella succinogenes L-asparaginase. Eur J Biochem 241, 201 207.
10. Lubkowski J, Wlodawer A, Housset D, Weber IT, Ammon HL, Murphy KC Swain AL (1994) Refined crystal structure of Acinetobacter glutaminasificans glutaminase-asparaginase. Acta Crystallogr D Biol Crystallogr 50, 826 832.
11. Lubkowski J, Wlodawer A, Ammon HL, Copeland TD Swain AL (1994) Structural characterization of Pseudomonas 7A glutaminase-asparaginase. Biochemistry 33, 10257 10265.
12. Lubkowski J, Dauter M, Aghaiypour K, Wlodawer A Dauter Z (2003) Atomic resolution structure of Erwinia chrysanthemi L-asparaginase. Acta Crystallogr D Biol Crystallogr 59, 84 92.
13. Ortlund E, Lacount MW, Lewinski K Lebioda L (2000) Reactions of Pseudomonas 7A glutaminase-asparaginase with diazo analogues of glutamine and asparagine result in unexpected covalent inhibitions and suggests an unusual catalytic triad Thr-Tyr-Glu. Biochemistry 39, 1199 1204.
14. Aung HP, Bocola M, Schleper S Rohm KH (2000) Dynamics of a mobile loop at the active site of Escherichia coli asparaginase. Biochim Biophys Acta 1481, 349 359.
15. Derst C, Henseling J Röhm KH (2000) Engineering the substrate specificity of Escherichia coli asparaginase. II. Selective reduction of glutaminase activity by amino acid replacements at position 248. Protein Sci 9, 2009 2017.
16. Avramis VI Tiwari PN (2006) Asparaginase (native ASNase or pegylated ASNase) in the treatment of acute lymphoblastic leukemia. Int J Nanomedicine 1, 241 254.
17. Distasio JA, Niederman RA, Kafkewitz D Goodman D (1976) Purification and characterization of L-asparaginase with anti-lymphoma activity from Vibrio succinogenes. J Biol Chem 251, 6929 6933.
18. Narta UK, Kanwar SS Azmi W (2007) Pharmacological and clinical evaluation of L-asparaginase in the treatment of leukemia. Crit Rev Oncol Hematol 61, 208 221.
19. Krasotkina J, Borisova AA, Gervaziev YV Sokolov NN (2004) One-step purification and kinetic properties of the recombinant L-asparaginase from Erwinia carotovora. Biotechnol Appl Biochem 39, 215 221.
20. Kotzia GA Labrou NE (2005) Cloning, expression and characterisation of Erwinia carotovora L-asparaginase. J Biotechnol 119, 309 323.
21. Carlsson H, Stockelberg D, Tengborn L, Braide I, Carneskog J Kutti J (1995) Effects of Erwinia-asparaginase on the coagulation system. Eur J Haematol 55, 289 293.
22. Eden OB, Shaw MP, Lilleyman JS Richards S (1990) Non-randomised study comparing toxicity of Escherichia coli and Erwinia asparaginase in children with leukaemia. Med Pediatr Oncol 18, 497 502.
23. Miller M, Rao JK, Wlodawer A Gribskov MR (1993) A left-handed crossover involved in amidohydrolase catalysis. Crystal structure of Erwinia chrysanthemi L-asparaginase with bound L-aspartate. FEBS Lett 328, 275 279.
24. Kotzia GA Labrou NE (2007) L-Asparaginase from Erwinia Chrysanthemi 3937: cloning, expression and characterization. J Biotechnol 127, 657 669.
25. Shifrin S, Luborsky SW Grochowski BJ (1971) L-Asparaginase from Escherichia coli B. Physicochemical studies of the dissociation process. J Biol Chem 246, 7708 7714.
26. Janin J, Rodier F, Chakrabarti P Bahadur RP (2007) Macromolecular recognition in the Protein Data Bank. Acta Crystallogr D Biol Crystallogr 63, 1 8.
27. Lawrence MC Colman PM (1993) Shape complementarity at protein/protein interfaces. J Mol Biol 234, 946 950.
28. Kirchbaum J, Wriston JC Ratych OT (1969) Subunit structure of asparaginase from Escherichia coli B. Biochim Biophys Acta Protein Struct 194, 161 169.
29. Vieira Pinheiro JP, Wenner K, Escherich G, Lanvers-Kaminsky C, Wurthwein G, Janka-Schaub G Boos J (2006) Serum asparaginase activities and asparagine concentrations in the cerebrospinal fluid after a single infusion of 2,500 IU/m(2) PEG asparaginase in children with ALL treated according to protocol COALL-06-97. Pediatr Blood Cancer 46, 18 25.
30. Goldberg JM, Silverman LB, Levy DE, Dalton VK, Gelber RD, Lehmann L, Cohen HJ, Sallan SE Asselin BL (2003) Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience. J Clin Oncol 21, 3616 3622.
31. Moghrabi A, Levy DE, Asselin B, Barr R, Clavell L, Hurwitz C, Samson Y, Schorin M, Dalton VK, Lipshultz SE et al. (2007) Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia. Blood 109, 896 904.
32. Wikman LE, Krasotkina J, Kuchumova A, Sokolov NN Papageorgiou AC (2005) Crystallization and preliminary crystallographic analysis of L-asparaginase from Erwinia carotovora. Acta Crystallogr F Struct Biol Cryst Commun 61, 407 409.
33. Kabsch W (1993) Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants. J Appl Crystallogr 26, 795 800.
34. McCoy AJ, Grosse-Kunstleve RW, Storoni LC Read RJ (2005) Likelihood-enhanced fast translation functions. Acta Crystallogr D Biol Crystallogr 61, 458 464.
35. Brunger AT, Adams PD, Clore GM, DeLano WL, Gros P, Grosse-Kunstleve RW, Jiang JS, Kuszewski J, Nilges M, Pannu NS et al. (1998) Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr 54, 905 921.
36. Murshudov GN, Vagin AA Dodson EJ (1997) Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr 53, 240 255.
37. Jones AT, Zou YJ Kjeldgaard M (1994) Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr A 42, 140 149.
38. Emsley P Cowtan K (2004) Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60, 2126 2132.
39. Morris RJ, Perrakis A Lamzin VS (2003) ARP/wARP and automatic interpretation of protein electron density maps. Methods Enzymol 374, 229 244.
40. Potterton E, Briggs P, Turkenburg M Dodson E (2003) A graphical user interface to the CCP4 program suite. Acta Crystallogr D Biol Crystallogr 59, 1131 1137.
41. Laskowski RA, MacArthur MW, Moss DS Thornton JM (1993) PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Crystallogr 26, 283 291.
42. Krissinel E Henrick K (2004) Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions. Acta Crystallogr D Biol Crystallogr 60, 2256 2268.
43. Meister A Fraser PE (1954) Enzymatic formation of L-asparagine by transamination. J Biol Chem 210, 37 43.
44. Denizot F Lang R (1986) Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 89, 271 277.
45. Kabsch W Sander C (1983) Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 22, 2577 2637.
46. Gouet P, Courcelle E, Stuart DI Metoz F (1999) ESPript: analysis of multiple sequence alignments in PostScript. Bioinformatics 15, 305 308.